Helix Biomedix Inc (HXBM)
23.27
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Helix Biomedix Max Drawdown (5Y): 74.63% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 74.63% |
| March 31, 2024 | 74.63% |
| February 29, 2024 | 74.63% |
| January 31, 2024 | 74.63% |
| December 31, 2023 | 74.63% |
| November 30, 2023 | 74.63% |
| October 31, 2023 | 74.63% |
| September 30, 2023 | 74.63% |
| August 31, 2023 | 74.63% |
| July 31, 2023 | 74.63% |
| June 30, 2023 | 74.63% |
| May 31, 2023 | 74.63% |
| April 30, 2023 | 74.63% |
| March 31, 2023 | 74.63% |
| February 28, 2023 | 74.63% |
| January 31, 2023 | 74.63% |
| December 31, 2022 | 74.63% |
| November 30, 2022 | 74.63% |
| October 31, 2022 | 74.63% |
| September 30, 2022 | 74.63% |
| August 31, 2022 | 74.63% |
| July 31, 2022 | 74.63% |
| June 30, 2022 | 74.63% |
| May 31, 2022 | 74.63% |
| April 30, 2022 | 74.63% |
| Date | Value |
|---|---|
| March 31, 2022 | 74.63% |
| February 28, 2022 | 74.63% |
| January 31, 2022 | 74.63% |
| December 31, 2021 | 74.63% |
| November 30, 2021 | 66.93% |
| October 31, 2021 | 66.93% |
| September 30, 2021 | 66.93% |
| August 31, 2021 | 66.93% |
| July 31, 2021 | 66.93% |
| June 30, 2021 | 66.93% |
| May 31, 2021 | 66.93% |
| April 30, 2021 | 66.93% |
| March 31, 2021 | 66.93% |
| February 28, 2021 | 66.93% |
| January 31, 2021 | 66.93% |
| December 31, 2020 | 66.93% |
| November 30, 2020 | 66.93% |
| October 31, 2020 | 66.67% |
| September 30, 2020 | 66.67% |
| August 31, 2020 | 66.57% |
| July 31, 2020 | 66.40% |
| June 30, 2020 | 69.00% |
| May 31, 2020 | 73.84% |
| April 30, 2020 | 73.84% |
| March 31, 2020 | 73.90% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
66.40%
Minimum
Jul 2020
84.75%
Maximum
May 2019
72.96%
Average
74.63%
Median
Dec 2021
Max Drawdown (5Y) Benchmarks
| CEL-SCI Corp | 96.13% |
| AIM ImmunoTech Inc | 99.76% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -19.07 |
| Beta (5Y) | 0.3405 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 48.20% |
| Historical Sharpe Ratio (5Y) | -0.3169 |
| Historical Sortino (5Y) | -0.4809 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 13.14% |